2026 Interim report
Filed with HKEX · Stock code 1521 · · 93 pages · English
Summary by 6ix AI
The report highlights a significant increase in revenue and net profit compared to the same period last year, reflecting strong operational growth. Additionally, the company completed the acquisition of Teddy Lab, enhancing its laboratory capabilities and expanding its service offerings. The report also discusses advancements in AI-assisted workflows and laboratory automation to improve efficiency and service delivery.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Frontage Holdings Corp. on 6ix
Earlier from Frontage
- Frontage Laboratories Completes Acquisition of Teddy Lab, Strengthening Global Central Laboratory Capabilities
- Frontage Laboratories Expands Early Phase Clinical Capabilities to Support Global Drug Development
- Frontage Europe Has Relocated Its Bioanalytical Laboratory and Further Expands Its Capabilities
- Frontage CDMO Fully Operational GMP Facility is Ready for Your Needs of Clinical Trials and Commercial Production
- Frontage Announces Expansion of Business in Canada with New Leadership
Later from Frontage
- Notification Letter and Reply Form for Registered Shareholders
- Notification Letter and Request Form for Non-Registered Shareholders
- Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2026
- Exchange notice - trading halt
- Trading halt
Follow Frontage into a list and get an email when it puts out news.
Follow Frontage